» Articles » PMID: 18555850

Effects of Soy Protein and Isoflavones on Insulin Resistance and Adiponectin in Male Monkeys

Overview
Journal Metabolism
Specialty Endocrinology
Date 2008 Jun 17
PMID 18555850
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Isoflavones may influence insulin action by means of their well-known receptor-mediated estrogenic activity. However, isoflavones also bind to peroxisome proliferator-activated receptors (PPARs) that are strongly associated with insulin action. Soy protein with its isoflavones has previously been shown to improve glycemic control in diabetic postmenopausal women and to improve insulin sensitivity in ovariectomized monkeys. The purpose of the current report was to extend our studies of dietary soy protein to male monkeys and determine effects of the soy isoflavones on insulin resistance. Two studies are reported here. Study one involved 91 male monkeys consuming 3 diets differing only by the source of protein (casein-lactalbumin, soy protein with a low isoflavone concentration, or soy protein with a high isoflavone concentration). Intravenous glucose tolerance tests were done, and plasma adiponectin and lipoprotein concentrations were determined after 25 months of study. Samples of visceral fat were obtained at 31 months for assessment of adiponectin and PPARgamma expression. The second study involved 8 monkeys in a Latin-square design that compared the effects of diets with casein/lactalbumin, soy protein with a high isoflavone concentration, or soy protein that was alcohol-washed to deplete the isoflavones. After 8 weeks of treatment, insulin sensitivity and plasma lipoproteins were assessed. At 10 weeks, a biopsy of the skeletal muscle was performed for determination of insulin receptor, PPARalpha, and PPARgamma content. The major findings were that consumption of isoflavone-containing soy protein dose-dependently increased insulin responses to the glucose challenge and decreased plasma adiponectin, whereas isoflavone-depleted soy protein decreased body weight and had no effect on plasma adiponectin concentrations. Muscle PPARalpha and gamma expression was also increased with the isoflavone-depleted soy relative to either casein or soy protein containing the isoflavones. Further studies are needed to determine the mechanisms involved in these effects of a high-soy isoflavone diet and to optimize dietary isoflavone content for maximal health benefits in male subjects.

Citing Articles

Impact of Prenatal Dietary Soy on Cerebellar Neurodevelopment and Function in Experimental Fetal Alcohol Spectrum Disorder.

de la Monte S, Tong M, Ziplow J, Mark P, Van S, Nguyen V Nutrients. 2025; 17(5).

PMID: 40077682 PMC: 11901751. DOI: 10.3390/nu17050812.


Association between dietary soy prevention of fetal alcohol spectrum disorder and normalization of placental insulin and insulin-like growth factor signaling networks and downstream effector molecule expression.

Gundogan F, Tong M, de la Monte S Gene Protein Dis. 2025; 3(2).

PMID: 39925675 PMC: 11807375. DOI: 10.36922/gpd.3113.


Differential rescue effects of choline chloride and soy isolate on metabolic dysfunction in immature central nervous system neurons: Relevance to fetal alcohol spectrum disorder.

de la Monte S, Elgas E, Tong M, Delikkaya B, Yang Y Diabetes Manag (Lond). 2024; 13(Suppl 1):107-118.

PMID: 39601020 PMC: 11595351.


Differential Early Mechanistic Frontal Lobe Responses to Choline Chloride and Soy Isoflavones in an Experimental Model of Fetal Alcohol Spectrum Disorder.

de la Monte S, Tong M, Delikkaya B Int J Mol Sci. 2023; 24(8).

PMID: 37108779 PMC: 10145811. DOI: 10.3390/ijms24087595.


Dietary soy prevents fetal demise, intrauterine growth restriction, craniofacial dysmorphic features, and impairments in placentation linked to gestational alcohol exposure: Pivotal role of insulin and insulin-like growth factor signaling networks.

Qi W, Gundogan F, Gilligan J, de la Monte S Alcohol. 2023; 110:65-81.

PMID: 36898643 PMC: 10272094. DOI: 10.1016/j.alcohol.2023.01.006.


References
1.
Adams M, Golden D, Williams J, Franke A, Register T, Kaplan J . Soy protein containing isoflavones reduces the size of atherosclerotic plaques without affecting coronary artery reactivity in adult male monkeys. J Nutr. 2005; 135(12):2852-6. DOI: 10.1093/jn/135.12.2852. View

2.
Hermansen K, Sondergaard M, Hoie L, Carstensen M, Brock B . Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care. 2001; 24(2):228-33. DOI: 10.2337/diacare.24.2.228. View

3.
Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K . Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006; 116(7):1784-92. PMC: 1483172. DOI: 10.1172/JCI29126. View

4.
Liu D, Zhen W, Yang Z, Carter J, Si H, Reynolds K . Genistein acutely stimulates insulin secretion in pancreatic beta-cells through a cAMP-dependent protein kinase pathway. Diabetes. 2006; 55(4):1043-50. DOI: 10.2337/diabetes.55.04.06.db05-1089. View

5.
Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N . Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987; 262(12):5592-5. View